Xtant Medical Holdings (XTNT) Free Cash Flow Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) Free Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | -0.27% |
| 10 | Xtant Medical Holdings | 61.70 Mn | 44.37 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 53.60% |
| Jun 30, 2025 | 70.15% |
| Mar 31, 2025 | 27.21% |
| Dec 31, 2024 | 67.45% |
| Sep 30, 2024 | -41.96% |
| Jun 30, 2024 | -74.37% |
| Mar 31, 2024 | -52.27% |
| Dec 31, 2023 | -87.55% |
| Sep 30, 2023 | -136.94% |
| Jun 30, 2023 | -144.02% |
| Mar 31, 2023 | -9.68% |
| Dec 31, 2022 | -70.91% |
| Sep 30, 2022 | -20.06% |
| Jun 30, 2022 | -40.90% |
| Mar 31, 2022 | -83.86% |
| Dec 31, 2021 | -28.49% |
| Sep 30, 2021 | -5.34% |
| Jun 30, 2021 | 235.21% |
| Mar 31, 2021 | -170.44% |
| Dec 31, 2020 | -15.51% |